Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
2024 ESC guidelines for the management of chronic coronary syndromes: developed by the task force for the management of chronic coronary syndromes of the …
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) …
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
Beta-blockers after myocardial infarction and preserved ejection fraction
T Yndigegn, B Lindahl, K Mars… - … England Journal of …, 2024 - Mass Medical Soc
Background Most trials that have shown a benefit of beta-blocker treatment after myocardial
infarction included patients with large myocardial infarctions and were conducted in an era …
infarction included patients with large myocardial infarctions and were conducted in an era …
2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure …
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
Dapagliflozin in myocardial infarction without diabetes or heart failure
Background In patients with acute myocardial infarction (MI), therapies that could further
reduce the risk of adverse cardiovascular and metabolic outcomes are needed. Methods In …
reduce the risk of adverse cardiovascular and metabolic outcomes are needed. Methods In …
FFR-guided complete or culprit-only PCI in patients with myocardial infarction
F Böhm, B Mogensen, T Engstrøm… - … England Journal of …, 2024 - Mass Medical Soc
Background The benefit of fractional flow reserve (FFR)–guided complete revascularization
in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel …
in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel …
Invasive treatment strategy for older patients with myocardial infarction
Background Whether a conservative strategy of medical therapy alone or a strategy of
medical therapy plus invasive treatment is more beneficial in older adults with non–ST …
medical therapy plus invasive treatment is more beneficial in older adults with non–ST …
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases: Developed by the task force on the management of peripheral arterial and aortic …
L Mazzolai, G Teixido-Tura, S Lanzi, V Boc… - European heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
Beta-blocker interruption or continuation after myocardial infarction
J Silvain, G Cayla, E Ferrari, G Range… - … England Journal of …, 2024 - Mass Medical Soc
Background The appropriate duration of treatment with beta-blocker drugs after a
myocardial infarction is unknown. Data are needed on the safety and efficacy of the …
myocardial infarction is unknown. Data are needed on the safety and efficacy of the …
Edoxaban antithrombotic therapy for atrial fibrillation and stable coronary artery disease
MS Cho, DY Kang, JM Ahn, SC Yun… - … England Journal of …, 2024 - Mass Medical Soc
Background Despite consistent recommendations from clinical guidelines, data from
randomized trials on a long-term antithrombotic treatment strategy for patients with atrial …
randomized trials on a long-term antithrombotic treatment strategy for patients with atrial …